Entero Therapeutics Inc (ENTO)
2.08
+0.01
(+0.48%)
USD |
NASDAQ |
Jun 17, 16:00
Entero Therapeutics Cash from Operations (TTM): -13.28M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -13.28M |
December 31, 2023 | -12.38M |
September 30, 2023 | -14.53M |
June 30, 2023 | -15.45M |
March 31, 2023 | -17.28M |
December 31, 2022 | -22.34M |
September 30, 2022 | -22.61M |
June 30, 2022 | -34.09M |
March 31, 2022 | -35.13M |
December 31, 2021 | -32.29M |
September 30, 2021 | -32.32M |
June 30, 2021 | -19.28M |
March 31, 2021 | -15.00M |
December 31, 2020 | -11.22M |
September 30, 2020 | -8.558M |
June 30, 2020 | -10.01M |
March 31, 2020 | -12.70M |
Date | Value |
---|---|
December 31, 2019 | -14.03M |
September 30, 2019 | -14.15M |
June 30, 2019 | -12.66M |
March 31, 2019 | -11.28M |
December 31, 2018 | -10.87M |
September 30, 2018 | -9.998M |
June 30, 2018 | -8.624M |
March 31, 2018 | -8.234M |
December 31, 2017 | -7.185M |
September 30, 2017 | -6.732M |
June 30, 2017 | -6.665M |
March 31, 2017 | -5.064M |
December 31, 2016 | -4.535M |
September 30, 2016 | -3.235M |
June 30, 2016 | -3.756M |
March 31, 2016 | -3.781M |
December 31, 2015 | -4.170M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-35.13M
Minimum
Mar 2022
-8.558M
Maximum
Sep 2020
-18.47M
Average
-14.77M
Median
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.516M |
Palatin Technologies Inc | -33.74M |
iBio Inc | -18.67M |
Theriva Biologics Inc | -18.27M |
Oragenics Inc | -8.246M |